The latest lymphoma news
Lymphoma: Key signaling pathway involved in tumour formation identified
There are myriad reasons why cancers develop. By studying genes which are altered in people…
Browsing: Lymphoma
Lymphoma cell metabolism may provide new cancer target
Diffuse large B cell lymphomas (DLBCLs) have a critical metabolic vulnerability that can be exploited…
Strange DNA structures may drive cancer development
Scientists at the La Jolla Institute for Immunology (LJI) in the USA have uncovered how…
Ibrutinib improves survival for younger people with diffuse large B-cell lymphoma
New evidence suggests that adding the targeted therapy ibrutinib (Imbruvica) to a standard chemotherapy regimen…
ASH 2021: ZUMA-7 demonstrates lasting benefits of CAR-T therapy over current standard of care for large B-cell lymphoma
Two-year data from the ZUMA-7 trial primary analysis show that the CAR T-cell therapy axicabtagene…
ASH 2021: TRANSFORM study reports CAR T-cell therapy liso-cel significantly improves outcomes for relapsed and refractory large B-cell lymphoma
An interim analysis of the TRANSFORM trial comparing CAR T-cell therapy lisocabtagene maraleucel (liso-cel) to…
ASH 2021: Axicabtagene ciloleucel shows durable responses after two years for patients with indolent non-Hodgkin lymphoma
Follow-up data from the Phase II ZUMA-5 trial showed a long-term survival benefit with axicabtagene ciloleucel (axi-cel)…
ASH 2021: Bispecific antibody mosunetuzumab brings deep remission for follicular lymphoma
A phase I/II trial for the experimental drug mosunetuzumab met its primary endpoint, leading to…
Study finds chemotherapy fails for some blood cancer patients because of crucial gene mutations
Mutations in a crucial gene are the key reason that chemotherapy fails in some patients…
The tricks of lymphomas
Cellular immunotherapies have so far not been very effective against non-Hodgkin’s lymphoma. A team led by…